Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 09, 2024 16:45 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 15, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1,...
Anika Reports Second Quarter 2024 Financial Results
August 08, 2024 16:05 ET
|
Anika Therapeutics Inc.
Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating...
Anika to Participate in the Sidoti Virtual Investor Conference
August 05, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 25, 2024 09:00 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 16, 2024 07:19 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1,...
Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon Repairs
July 11, 2024 08:30 ET
|
Anika Therapeutics Inc.
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 07, 2024 16:01 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on June 3,...
Anika Enters into Cooperation Agreement with Caligan Partners
May 28, 2024 16:05 ET
|
Anika Therapeutics Inc.
Appoints Joseph Capper and William Jellison to Board of DirectorsAnnounces New $40 Million Share Repurchase Program BEDFORD, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
Anika Announces CFO Transition
May 08, 2024 16:08 ET
|
Anika Therapeutics Inc.
BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that it has appointed...